Orbimed Advisors LLC Ascendis Pharma A/S Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $50.5 Million - $79.2 Million	-447,859 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $6.97 Million - $8.33 Million	-57,300 Reduced 11.34%	447,859 $58.9 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $21.1 Million - $29.2 Million	168,659 Added 50.12%	505,159 $65.1 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $60.2 Million - $72.7 Million	-398,000 Reduced 54.19%	336,500 $56.1 Million
Q3 2020 Nov 16, 2020	SELL	$134.29 - $154.32 $111 Million - $128 Million	-828,486 Reduced 53.01%	734,500 $113 Million
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $191 Million - $269 Million	-1,724,414 Reduced 52.46%	1,562,986 $231 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $5.4 Million - $8.08 Million	-55,700 Reduced 1.67%	3,287,400 $370 Million
Q4 2019 Feb 14, 2020	SELL	$91.45 - $139.12 $34.4 Million - $52.3 Million	-376,073 Reduced 10.11%	3,343,100 $465 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $12.2 Million - $15.2 Million	-127,500 Reduced 3.31%	3,719,173 $358 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $13.3 Million - $16.4 Million	-124,000 Reduced 3.12%	3,846,673 $443 Million
Q1 2019 May 15, 2019	SELL	$62.15 - $129.99 $7.25 Million - $15.2 Million	-116,700 Reduced 2.86%	3,970,673 $467 Million
Q4 2018 Feb 14, 2019	SELL	$55.16 - $69.67 $3.78 Million - $4.77 Million	-68,518 Reduced 1.65%	4,087,373 $256 Million
Q3 2018 Nov 14, 2018	SELL	$63.77 - $76.28 $16.4 Million - $19.6 Million	-257,400 Reduced 5.83%	4,155,891 $294 Million
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $61.2 Million - $77.3 Million	1,045,976 Added 31.06%	4,413,291 $294 Million
Q3 2017 Nov 14, 2017	BUY	$26.89 - $37.1 $90.5 Million - $125 Million	3,367,315	3,367,315 $122 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.34 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$707 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$687 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$608 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$577 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.69B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account